Nauling, Forlisa External Entity

Publications

Sort by

Selected publications

  • Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.  Journal of clinical oncology : official journal of the American Society of Clinical Oncology2011 Academic Article GET IT
    Times cited: 286

Other